source
- Incyte reports lasting tumor responses in pancreatic cancer patients using targeted drug plus chemotherapyIncyte announced at the European Society for Medical Oncology meeting that its targeted therapy, when combined with standard chemotherapy, produced durable tumor responses in a subset of pancreatic…
- Boehringer Ingelheim and Microsoft launch AI partnership to develop digital patient twins for clinical trialsBoehringer Ingelheim and Microsoft announced a collaboration to investigate AI driven digital patient twins that model individual patients for clinical trial design. The work will explore disease…